Forbes recently released its list of the 400 richest people in the country. Eleven of them live in Nevada. See who they are.

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.

On August 18, 2026, Hims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum told CNBC that a Federal Trade Commission lawsuit over the company’s data-sharing and subscription practices “misunderstands ...

The National Advertising Division (NAD) has delivered a mixed verdict in a row over hair-loss ads, telling Hims & Hers Health to change certain claims while dismissing other challenges brought by ...

Andrew Mountbatten-Windsor reportedly feels "abandoned" by his family as his royal exile deepens. British broadcaster and photographer Helena Chard told Fox News Digital that friends are reportedly ...

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more. As ...

- Hims & Hers HIMS--CEO Andrew Dudum's Form 4 filing shows 78,859 shares "disposed" via tax withholding from vested RSUs, not voluntary sales. - Since 2021, Dudum has sold ~7.5M shares ($191M) vs.

Stock-based compensation vesting triggered mandatory tax withholding, but Dudum retains about 9.7 million shares worth $272 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Transaction value based on SEC Form 4 weighted average sale price ($28.15); post-transaction value based on the August 14 market close ($28.15). Hims & Hers Health operates as a leading digital health ...

The Hims and Hers CEO said that companies with their own datasets stand to save a lot of money by using open-weight models.NYSE One executive is touting open-weight models, especially if your company ...

In a wide-ranging interview with CNBC aired on Tuesday, Andrew Dudum, CEO of Hims & Hers (HIMS), defended his company against a recent FTC lawsuit and projected that prices of GLP-1 drugs could ...